East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Hydrocortisone Tablets USP, 5 mg, 10 mg, and 20 mg. Aurobindo Pharma’s Hydrocortisone Tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), CORTEF® tablets manufactured by Pharmacia and Upjohn Co.

Hydrocortisone Tablets are indicated in the following conditions:

• Endocrine Disorders
• Rheumatic Disorders
• Collagen Diseases
• Dermatologic Diseases
• Allergic States
• Ophthalmic Diseases
• Respiratory Diseases
• Hematologic Disorders
• Neoplastic Diseases
• Edematous States
• Gastrointestinal Diseases.